Results 181 to 190 of about 2,338 (236)
Some of the next articles are maybe not open access.
PROTRACTED PARENTERAL DRUG INFUSION IN AMBULATORY SUBJECTS USING AN IMPLANTABLE INFUSION PUMP
ASAIO Journal, 1977This study demonstrates the feasibility of ambulatory heparin therapy and its potential for successful treatment of refractory thromboembolic disease. The proven capability of the implantable infusion pump to provide long-term heparin infusion in ambulatory subjects suggests that it may have application in the delivery of other parenteral drugs as well.
T D, Rohde +3 more
openaire +2 more sources
Implantable Insulin Infusion Pumps: A Case Presentation
The Diabetes Educator, 1989A case is presented of a young woman implanted with a program mable implantable medication system (PIMS). Implanted insulin pumps have been the subject of research for over a decade but have encountered a series of obstacles ranging from design problems to insulin aggregation to catheter blocking from omental tissue. Many of these problems, but not all,
openaire +2 more sources
In-111 DTPA to Evaluate the Patency of an Implanted Intrathecal Infusion Pump
CLINICAL NUCLEAR MEDICINE, 1997In-111 DTPA cisternography confirmed placement and patency of a slow flow, implanted, programmable, intrathecal morphine infusion pump system. Other radiologic methods failed and were impractical.
E, Schmidt, E, Oates
openaire +2 more sources
An Implantable Pump for Intrarenal Infusion of Immunosuppressants in a Canine Autotransplant Model
Pharmaceutical Research, 1988We developed a canine renal allograft model utilizing implantable infusion pumps and biocompatible catheters to investigate the pharmacokinetics of local immunosuppressive drug administration. Seven mongrel dogs underwent bilateral nephrectomy and autotransplantation of one kidney to the iliac vessels.
Scott A. Gruber +11 more
openaire +2 more sources
The totally implantable Infusion Pump in treatment of metastatic colorectal cancer
Diseases of the Colon & Rectum, 1985Final evaluation of the Infusaid Pump system (Infusaid Corporation, Sharon, MA) for administration of regional chemotherapy must await completion of trials prospectively comparing survival of matched patients treated in this manner and patients treated by traditional systemic chemotherapy.
G C, Oliver, P E, Shorb
openaire +2 more sources
Regional hepatic chemotherapy using an implantable drug infusion pump
The American Journal of Surgery, 1983Regional infusion of chemotherapeutic agents in the treatment of liver cancer can greatly increase tumor exposure to certain drugs. Exposure is 100 times greater with floxuridine, 6 times greater with mitomycin C, and 6 times greater with BCNU. The Model 400 Infusaid implantable, refillable drug infusion pump overcomes much of the discomfort and ...
A M, Cohen +3 more
openaire +2 more sources
Transbrachial hepatic arterial chemotherapy using an implanted infusion pump
Diseases of the Colon & Rectum, 1980Two patients with hepatic metastases from colonic cancer were treated with hepatic arterial FUDR using an innovative drug infusion system. The two patients reported underwent transbrachial hepatic artery catheterization with a 5 French polyethylene catheter.
A M, Cohen +5 more
openaire +2 more sources
[40] Implantable infusion pumps: Practical aspects
1985Publisher Summary This chapter discusses the practical aspects of implantable infusion pumps. The chapter discusses the pump implantation in humans. As with the implantation of any foreign body, the development of an infection at the site of infusion pump implantation usually requires pump removal.
Perry J. Blackshear +3 more
openaire +1 more source
Head & Neck Surgery, 1981
AbstractIntraarterial infusion chemotherapy has not been widely accepted for the treatment of head and neck cancer due to the high rate of complications it involves. To avoid these complications, a totally implantable infusion pump has been developed to achieve continuous low‐level drug delivery for long periods of time.
S R, Baker +3 more
openaire +2 more sources
AbstractIntraarterial infusion chemotherapy has not been widely accepted for the treatment of head and neck cancer due to the high rate of complications it involves. To avoid these complications, a totally implantable infusion pump has been developed to achieve continuous low‐level drug delivery for long periods of time.
S R, Baker +3 more
openaire +2 more sources
The implantable “Infusaid” infusion pump: The Sydney experience using 5‐fluorouracil
Medical Journal of Australia, 1986The experience is reported of the use of the totally implantable "Infusaid" infusion pump in the treatment of 14 patients in our combined clinics for metastatic carcinoma in the liver by means of the antimetabolite 5-FU. At the time of this study the more active antimetabolite 5-FUDR was not available.
Stephens, F. O., Crea, P., Walker, P. J.
openaire +4 more sources

